COVID-19 in Adults with Congenital Heart Disease

Protocol Description

To better understand the burden and impact of COVID-19 on adult congenital heart disease (ACHD) patients, this research maintains a multi-center database of ACHD patients who have tested positive for SARS-CoV-2 infection and are considered to have contracted COVID-19. Using the REDCap (Research Electronic Data Capture) data management platform, this research is determining the prevalence of COVID-19 among ACHD patients and helping clinicians to identify risk factors for those likely to develop more severe complications. The database also enables the sharing of health care management practices to optimize results for patients

Eligibility Criteria

The study population comprises patients ages 18 and older with congenital heart disease who undergo testing for SARS-CoV-2 at participating centers and are considered to have contracted COVID-19.
Males and Females: Ages 18 and older


There are no requirements for participants. Clinical data is taken from the medical record for review and analysis.
Visits: None required
Duration: Not applicable

Status: Enrolls from Current Patient Cases

Primary Investigator

Arvind Hoskoppal, MD

Contact Information

For more information about the study, please contact:
Morgan Hindes, Research Coordinator